Lillian Werner

Dana-Farber Cancer Institute

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 14 papers. Top paper: “Germline copy number variation associated with Mendelian inheritance of CLL in two families”.

Germline copy number variation associated with Mendelian inheritance of CLL in two families

Leukemia(2012)10.1038/leu.2012.33

N/A

0.627DataRank · unranked

11 citations

A Vartanov, M Ash, Christine A. Roden, Laura MacConaill, U Hainz +21 more

1.11 Integrative Genomic Analysis Implicates PIK3CA and MYC in Chronic Lymphocytic Leukemia

Clinical Lymphoma Myeloma and Leukemia(2011)10.1016/j.clml.2011.09.012

N/A

0.133DataRank · unranked

1 citations

Megan Hanna, Bethany Tesar, Lillian Werner, Nathalie Pochet, John M. Asara +13 more

Risk Alleles Identified in Genome-Wide Association Studies Are Associated with Expression Quantitative Trait Loci in Chronic Lymphocytic Leukemia.

Blood(2012)10.1182/blood.v120.21.2875.2875

N/A

0.104DataRank · unranked

1 citations

Lillian Werner, Megan Hanna, Ma. Reina Improgo, Nathalie Pochet, Stacey M. Fernandes +8 more

Data from Integrative Genomic Analysis Implicates Gain of PIK3CA at 3q26 and MYC at 8q24 in Chronic Lymphocytic Leukemia

(2023)10.1158/1078-0432.c.6520068

N/A

0DataRank · unranked

0 citations

Megan Hanna, Bethany Tesar, Lillian Werner, Nathalie Pochet, John M. Asara +13 more

Supplementary Table 6 from Integrative Genomic Analysis Implicates Gain of PIK3CA at 3q26 and MYC at 8q24 in Chronic Lymphocytic Leukemia

(2023)10.1158/1078-0432.22444134

N/A

0DataRank · unranked

0 citations

Megan Hanna, Bethany Tesar, Lillian Werner, Nathalie Pochet, John M. Asara +13 more

Data from Integrative Genomic Analysis Implicates Gain of PIK3CA at 3q26 and MYC at 8q24 in Chronic Lymphocytic Leukemia

(2023)10.1158/1078-0432.c.6520068.v1

N/A

0DataRank · unranked

0 citations

Megan Hanna, Bethany Tesar, Lillian Werner, Nathalie Pochet, John M. Asara +13 more

Supplementary Table 6 from Integrative Genomic Analysis Implicates Gain of PIK3CA at 3q26 and MYC at 8q24 in Chronic Lymphocytic Leukemia

INDIGO (University of Illinois at Chicago)(2023)10.1158/1078-0432.22444134.v1

N/A

0DataRank · unranked

0 citations

Megan Hanna, Bethany Tesar, Lillian Werner, Nathalie Pochet, John M. Asara +13 more

Supplementary Methods, Figures 1-4 and Tables 1 - 5, 7 - 15 from Integrative Genomic Analysis Implicates Gain of PIK3CA at 3q26 and MYC at 8q24 in Chronic Lymphocytic Leukemia

INDIGO (University of Illinois at Chicago)(2023)10.1158/1078-0432.22444137.v1

N/A

0DataRank · unranked

0 citations

Megan Hanna, Bethany Tesar, Lillian Werner, Nathalie Pochet, John M. Asara +13 more

Association of clonal hematopoiesis with chronic obstructive pulmonary disease

Blood(2021)10.1182/blood.2021013531

N/A

0DataRank · unranked

231 citations

Dandi Qiao, Joselyn Rojas, Michael C. Honigberg, Adam S. Sperling, Christopher J. Gibson +39 more

Genomic profiling of a randomized trial of interferon-α vs hydroxyurea in MPN reveals mutation-specific responses

Blood Advances(2021)10.1182/bloodadvances.2021004856

N/A

0DataRank · unranked

64 citations

Vibe Skov, Kristen E. Stevenson, Lillian Werner, William S. Duke, Charles Laurore +27 more

Treatment-free survival over extended follow-up of patients with advanced melanoma treated with immune checkpoint inhibitors in CheckMate 067

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2021-003743

N/A

0DataRank · unranked

36 citations

Charlene Mantia, Lillian Werner, Ahmad A. Tarhini, James Larkin, F. Stephen Hodi +10 more

Treatment-free Survival after Immune Checkpoint Inhibitor Therapy versus Targeted Therapy for Advanced Renal Cell Carcinoma: 42-Month Results of the CheckMate 214 Trial

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-2283

N/A

0DataRank · unranked

57 citations

Opeyemi A. Jegede, Charlene M. Mantia, Thomas Powles, Lillian Werner, Robert J. Motzer +16 more

ZNF683 marks a CD8+ T cell population associated with anti-tumor immunity following anti-PD-1 therapy for Richter syndrome

Cancer Cell(2023)10.1016/j.ccell.2023.08.013

N/A

0DataRank · unranked

73 citations

Camilla K. Lemvigh, Stephanie L. Deng, Nathan Dangle, Neil Ruthen, Binyamin A. Knisbacher +30 more

Data from Phase II Study of Dasatinib in Relapsed or Refractory Chronic Lymphocytic Leukemia

(2023)10.1158/1078-0432.c.6518805.v1

N/A

0DataRank · unranked

0 citations

Eyal C. Attar, Tak Takvorian, Ephraim P. Hochberg, Karen K. Ballen, K. Leahy +9 more